Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Long-Term Investments (2012 - 2026)

Precigen (PGEN) posted quarterly Long-Term Investments of $489000.0 for Q1 2026, down 34.8% year-over-year from $750000.0 in Q1 2025, and down 80.53% quarter-over-quarter from $2.5 million in Q4 2025.

Analysis

Precigen (PGEN) Long-Term Investments (2012 - 2026) Analysis & Trends

Precigen (PGEN) has reported Long-Term Investments for 14 consecutive years, with $489000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Long-Term Investments fell 34.8% year-over-year to $489000.0; the TTM figure through Mar 2026 stood at $489000.0 (down 34.8% YoY), while the FY2025 annual figure was $2.5 million, changed N/A from the prior year.
  • Long-Term Investments declined to $489000.0 in Q1 2026 per PGEN's latest filing, from $2.5 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $29.9 million in Q1 2022 and bottomed at $489000.0 in Q1 2026.
  • Historically, Long-Term Investments has averaged $7.5 million across 4 years, with a median of $5.3 million in 2023.
  • Annual changes were most pronounced in 2022 — Long-Term Investments sank 86.07% — and 2026, when it sank 34.8%.
  • Precigen's Long-Term Investments stood at $11.9 million in 2022, then slumped by 55.62% to $5.3 million in 2023, then slumped by 52.36% to $2.5 million in 2025, then tumbled by 80.53% to $489000.0 in 2026.
  • Business Quant data shows PGEN's Long-Term Investments at $489000.0 in Q1 2026, $2.5 million in Q4 2025, and $2.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 5.79 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 9.83 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -4.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1.77 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 22.17 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 372.10 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn 490,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 490,000.00
Mar 31, 2026 489,000.00
Dec 31, 2025 2.51 Mn
Sep 30, 2025 2.51 Mn
Mar 31, 2025 750,000.00
Sep 30, 2023 5.27 Mn
Jun 30, 2023 7.13 Mn
Mar 31, 2023 7.46 Mn
Jun 30, 2022 11.88 Mn
Mar 31, 2022 29.91 Mn
Dec 31, 2021 48.56 Mn
Sep 30, 2021 66.93 Mn
Jun 30, 2021 85.27 Mn
Mar 31, 2021 103.61 Mn
Sep 30, 2020 337,000.00
Jun 30, 2020 859,000.00
Mar 31, 2020 1.11 Mn
Dec 31, 2019 1.46 Mn
Sep 30, 2019 17.49 Mn
Jun 30, 2019 21.50 Mn